I’m Dr. George Ibrahim, and I’m going to explain a little bit about what stress urinary incontinence is, what causes it and touch on what can be done about it. Urologists specialize in urinary problems in both men and women. As a Duke trained urologist
Vaginal Sling and Mesh for Treating Incontinence I’d like to discuss a topic that you don’t hear about that often, but is extremely common amongst women. Urinary Continence Induced Bladder Leakage Bladder leakage caused by stress urinary incontinence affects millions of women in the US.
On July 17, 2025, the U.S. Food and Drug Administration (FDA) hosted a landmark expert panel to address longstanding controversies surrounding hormone replacement therapy (HRT)
Dr. Howard Hodis, professor of medicine and a landmark figure in cardiovascular research, delivered a thorough analysis of how HRT timing determines its effect profile.
Dr. Rachel S. Rubin, fellowship-trained urologist and sexual medicine expert, used her time to elevate the discussion around genital and urinary syndrome of menopause (GSM).
Mary Jane Minkin, MD, veteran OB/GYN and menopause educator, presented a comprehensive critique of the “one-size-fits-all” black box warning on estrogen therapies, focusing especially on
Dr. Kelly Casperson brought a unique perspective as a urologist and sexual health expert, focusing attention on the regulatory and clinical neglect faced by women
Dr. Vonda Wright, a leading authority on musculoskeletal health and aging, offered a no-nonsense appraisal of estrogen’s role in maintaining bone health after menopause. Describing
Roberta Diaz Brinton, PhD, a neuroscientist and international authority in women’s brain health, broadened the scope of the panel by linking menopause to the rising
Dr. Philip Sarrel presented a compelling case for expanding hormonal therapy conversations to encompass mental as well as physical health. Citing epidemiological studies and his
Dr. James Simon, an eminent clinical researcher in menopause and hormone therapy, delivered a nuanced exploration of how the timing of hormone replacement profoundly influences
Dr. JoAnn Pinkerton, a prominent leader in gynecology and menopause care, presented a passionate and evidence-back call to overhaul FDA boxed warnings on hormonal therapies.
Dr. Barbara Levy, a renowned gynecologist and specialist in women’s health, spoke with urgency about the need to update FDA warnings on hormone therapy for
Dr. Heather Hirsch’s presentation powerfully challenged longstanding dogma around hormone therapy (HRT) for menopause. Citing her experience as an internist with advanced women’s health training,
Supported by:
The Menopause Association
4301 50th Street NW
Suite 300-1090
Washington, DC 20013
FOR WOMEN
FOR PROVIDERS
REDEFINING MENOPAUSE
The Menopause Association is a non-profit organization, granted tax-exempt status under Section 501(c)(3) of the United States Internal Revenue Code. Contributions are tax-deductible to the extent allowable by law.
© - Redefining Menopause Provided by The Menopause Association | Platinum Media Solutions | All rights reserved